Filing Flows › Marimed (MRMD) › Next earnings date
Marimed (MRMD) earnings on Nov 11, 2026: what to expect
Marimed (MRMD) is expected to report earnings on Nov 11, 2026, in 3 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.01 (1 estimate) on revenue of $41.2M, against −$0.01 and $40.8M a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 66% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.01 on revenue of $43.9M, against the analysts' −$0.01.
The last report
Marimed reported revenue of $41.9M for the second quarter 2026 (+6% Y/Y), net loss $3.6M: Product sales - retail $23.2M, Product sales - wholesale $18.5M, Other revenue $193K. How it makes money → · Every quarter →
Marimed's latest quarter
Marimed, Q2 2026: revenue $41.9M (+6% year over year), operating margin 1.0%, net loss $3.6M, operating cash flow $2.2M. The chart follows the revenue to costs, profit and cash.
Questions
When does MRMD report earnings?
Marimed is expected to report on Nov 11, 2026.
What are analysts expecting from Marimed?
EPS of −$0.01 and revenue of $41.2M for the quarter.
Does Marimed usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.